Acute and chronic endothelial dysfunction: implications for the development of heart failure

Area of Science:

• Cardiovascular Physiology
• Molecular Biology
• Pharmacology

Background:

• Heart failure is traditionally linked to cardiac myocyte dysfunction and reduced cardiac output.
• A significant vascular component, particularly involving nitric oxide (NO), is increasingly recognized in heart failure pathogenesis.
• The role of NO in heart failure has evolved from deficiency to complex dysregulation.

Purpose of the Study:

• To review the evolving understanding of nitric oxide's role in heart failure development.
• To explore the shift in perspective from NO deficiency to NO overproduction by inducible NO synthase (iNOS).
• To discuss therapeutic strategies targeting NO pathways in heart failure.

Main Methods:

• Literature review of studies on nitric oxide synthase (NOS) isoforms and NO bioavailability in heart failure models and patients.
• Analysis of the impact of altered NO production, scavenging, and substrate availability on cardiac function.
• Examination of therapeutic interventions targeting NO-related mechanisms in heart failure.

Main Results:

• Reduced NO production and bioavailability are key factors in heart failure.
• Inducible NO synthase (iNOS) may produce excessive NO, suppressing cardiac myocyte function.
• Multiple NO-related pathways (substrate availability, superoxide scavenging, iNOS activity) are implicated in heart failure.

Conclusions:

• The role of NO in heart failure is multifaceted, involving both deficiency and excess.
• Therapeutic approaches must address the complex NO dysregulation in heart failure.
• Further research into NO pathways is crucial for developing effective heart failure treatments.